Thu, April 20, 2023
Wed, April 19, 2023
Tue, April 18, 2023

Serge Belanger Reiterated (ARQT) at Strong Buy and Held Target at $24 on, Apr 19th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-24-on-apr-19th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Serge Belanger of Needham, Reiterated "Arcutis Biotherapeutics, Inc." (ARQT) at Strong Buy and Held Target at $24 on, Apr 19th, 2023.

Serge has made no other calls on ARQT in the last 4 months.



There are 4 other peers that have a rating on ARQT. Out of the 4 peers that are also analyzing ARQT, 0 agree with Serge's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Serge


  • Nigel Dally of "Morgan Stanley" Maintained at Buy with Decreased Target to $47 on, Wednesday, April 12th, 2023
  • Uy Ear of "Mizuho" Reiterated at Strong Buy and Held Target at $61 on, Tuesday, April 11th, 2023
  • Gregory Fraser of "Truist Securities" Maintained at Strong Buy with Decreased Target to $45 on, Wednesday, March 29th, 2023
  • Vikram Purohit of "Morgan Stanley" Maintained at Buy with Decreased Target to $50 on, Wednesday, March 1st, 2023

Publication Contributing Sources